ADA Scientific Sessions 2026 Abstract
ABK-GIPR-1, an Oral Small-Molecule GIPR Antagonist, Enhanced GLP-1RA’s Efficacy in Reducing Body Weight and Improving Metabolic Profile in Preclinical Obesity Models
Experiments in animalsInterventions
Papers by Hongping Yu
1 result